-
NICE advises restricted use of antibiotics for COPD
- July 10, 2018
- Posted by: PharmaScroll
- Category:
No Comments -
Bellerophon to Present Positive Results from Phase 2 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with COPD at ATS Conference
- May 16, 2018
- Posted by: PharmaScroll
- Category:
-
AstraZeneca’s Fasenra Fails in Phase III COPD Trial
- May 11, 2018
- Posted by: PharmaScroll
- Category:
-
Verona Pharma to Present Clinical Trial Data of RPL554 at ATS (American Thoracic Society 2018) Conference
- May 9, 2018
- Posted by: PharmaScroll
- Category:
-
Verona Pharma to Mark its Presence at BioEquity Europe 2018
- May 5, 2018
- Posted by: PharmaScroll
- Category:
-
Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD
- April 25, 2018
- Posted by: PharmaScroll
- Category:
-
Novartis updates Launch Timeline for Advair Copy to 2019
- April 22, 2018
- Posted by: PharmaScroll
- Category:
-
GSK Appoints Senior Executive from Roche to Accelerate Pipeline Growth
- April 20, 2018
- Posted by: PharmaScroll
- Category:
-
Trelegy Ellipta – IMPACT Study Shows Significant Benefits in COPD Patients
- April 19, 2018
- Posted by: PharmaScroll
- Category: